Kingdon Capital Management, L.L.C. En V Veno Medical Corp Transaction History
Kingdon Capital Management, L.L.C.
- $639 Million
- Q2 2025
A detailed history of Kingdon Capital Management, L.L.C. transactions in En V Veno Medical Corp stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 859,261 shares of NVNO stock, worth $3.94 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
859,261
Previous 859,261
-0.0%
Holding current value
$3.94 Million
Previous $2.26 Million
51.75%
% of portfolio
0.54%
Previous 0.26%
Shares
4 transactions
Others Institutions Holding NVNO
# of Institutions
38Shares Held
5.48MCall Options Held
29KPut Options Held
0-
Perceptive Advisors LLC New York, NY1.28MShares$5.89 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA698KShares$3.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT595KShares$2.72 Million0.1% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.84 Million3.48% of portfolio
-
Westside Investment Management, Inc.280KShares$1.28 Million0.21% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $43.4M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...